|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-23-310336 |
H00000239-D01P |
12 Lipoxygenase Antibody//Human/Rabbit |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
12 Lipoxygenase Antibody |
Description
|
/ Human/Rabbit |
Clonality
|
Poly |
Company
|
Novus biologicals |
Application
|
ELISA, Western Blot |
Conjugation
|
|
Immunogen
|
|
Contents
|
Description:Summary: Species: | Hu | Applications: | ELISA, WB | Clonality: | Polyclonal | | Gene: | ALOX12 | Purity: | protein A purified | Host: | Rabbit | | Specificity: | ALOX12 - arachidonate 12-lipoxygenase, | Details: Immunogen: | ALOX12 (NP_000688.1, 1 a.a. ~ 663 a.a) full-length human protein. | Epitope: | MGRYRIRVATGAWLFSGSYNRVQLWL VGTRGEAELELQLRPARGEEEEFDHD VAEDLGLLQFVRLRKHHWLVDDAWFC DRITVQGPGACAEVAFPCYRWVQGED ILSLPEGTARLPGDNALDMFQKHREK ELKDRQQIYCWATWKEGLPLTIAADR KDDLPPNMRFHEEKRLDFEWTLKAGA LEMALKRVYTLLSSWNCLEDFDQIFW GQKSALAEKVRQCWQDDELFSYQFLN GANPMLLRRSTSLPSRLVLPS | Gene Symbol: ALOX12 Entrez: | 239 (Human) | Swiss Prot: | NP_000688.1 (Human) | Related Genes: | ALOX15, ALOX5, 12-LO, LOX, PTGS2, EGF, AGT, MAPK1, 12/15-LOX, ALOX12B, CASP3, JUN, INS, CD19, DAND5, PSG1, SP1, ALOXE3, MAPK3, APP, YWHAZ, COX8A, COX5A, SGCG, IL4, ATP6V0A4, PLP2, PTGS1, ALOX15B, ANG, CAT, EPHB2, CCL2, PKC, TNF, PPARG, CDKN1A, MAPK8, BCL2, VEGFA | Species: Applications: Uses: | Antibody reactive against recombinant protein with GST tag on ELISA and western blot and also on transfected lysate in western blot. GST tag alone is used as a negative control. | Dilutions: | Western Blot 1:500,ELISA | Notes: This product is produced by and distributed for Abnova, a company based in Taiwan. Packaging: Storage: | Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | Preservative: | No Preservative | Limitations: | This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months. | |
|
|
|
|